tadapox
| Product dosage: 80mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.03 | $40.31 (0%) | 🛒 Add to cart |
| 20 | $2.52 | $80.61 $50.38 (38%) | 🛒 Add to cart |
| 30 | $2.02 | $120.92 $60.46 (50%) | 🛒 Add to cart |
| 60 | $1.51 | $241.84 $90.69 (62%) | 🛒 Add to cart |
| 90 | $1.34 | $362.76 $120.92 (67%) | 🛒 Add to cart |
| 120 | $1.43 | $483.68 $171.30 (65%) | 🛒 Add to cart |
| 180 | $1.23 | $725.52 $221.69 (69%) | 🛒 Add to cart |
| 270 | $1.08 | $1088.28 $292.22 (73%) | 🛒 Add to cart |
| 360 | $0.92
Best per pill | $1451.05 $332.53 (77%) | 🛒 Add to cart |
Let me walk you through what we’ve observed with Tadapox in clinical practice over the past several years. When this combination product first appeared on the market, our urology department was frankly skeptical - the concept of combining tadalafil (Cialis) with dapoxetine (Priligy) seemed almost too convenient for addressing both erectile dysfunction and premature ejaculation simultaneously. But the clinical reality has proven more nuanced than we initially anticipated.
## Tadapox Composition and Pharmaceutical Profile
Tadapox contains two active pharmaceutical ingredients in fixed-dose combination:
- Tadalafil 20mg (phosphodiesterase type 5 inhibitor)
- Dapoxetine 30mg or 60mg (selective serotonin reuptake inhibitor)
The formulation typically comes as film-coated tablets with specific excipients to modulate the different pharmacokinetic profiles of these compounds. What’s interesting from a clinical pharmacology perspective is how these two medications interact physiologically - tadalafil with its 17.5-hour half-life providing sustained erectile support, while dapoxetine with its rapid absorption and short 1.5-hour half-life targets the acute premature ejaculation component.
We initially struggled with patient education around the timing of administration - many patients would take Tadapox right before sexual activity expecting both components to work immediately, not understanding that while dapoxetine needs 1-3 hours for optimal effect, tadalafil’s benefits persist throughout the day. This led to our developing specific timing protocols that I’ll detail in the dosage section.
## Mechanism of Action: Dual Pathway Approach
The dual mechanism represents one of the more elegant approaches to sexual dysfunction we’ve seen. Tadalafil works through PDE5 inhibition in the corpus cavernosum, increasing cyclic GMP and facilitating the nitric oxide-mediated vasodilation necessary for erection. Meanwhile, dapoxetine acts centrally on serotonin receptors in the ejaculatory center of the brain, increasing synaptic serotonin and raising the threshold for ejaculatory reflex.
What surprised us in practice was the apparent synergistic effect - patients reported better outcomes than we would have predicted from simply adding the individual effects. We theorize this might relate to reduced performance anxiety when both conditions are addressed simultaneously, though the exact psychophysiological interplay deserves further study.
## Clinical Applications and Patient Selection
We’ve found Tadapox most beneficial for men with comorbid erectile dysfunction and premature ejaculation - which, in our clinic, represents approximately 40% of patients presenting with sexual dysfunction. The key is proper patient selection.
Take Mark, a 52-year-old hypertensive on amlodipine who presented with both conditions. His initial concern was primarily the premature ejaculation, but careful history revealed underlying vasculogenic ED. Starting him on Tadapox 20/30mg produced dramatic improvement in both parameters - his IELT increased from 45 seconds to approximately 4 minutes, while his erectile function scores normalized.
However, we had a learning curve with patient selection. Early on, we prescribed Tadapox to David, a 38-year-old with lifelong premature ejaculation but normal erectile function. The tadalafil component provided no additional benefit while increasing side effect burden. We now reserve Tadapox specifically for true comorbid cases.
## Dosing Protocols and Administration Timing
Our current protocol involves significant patient education:
- Take 1-3 hours before anticipated sexual activity
- Can be taken with or without food, though high-fat meals delay dapoxetine absorption
- Start with lower dose (20/30mg) and titrate based on response and tolerability
- Maximum frequency: once daily
We created a simple table for patients:
| Clinical Scenario | Initial Dose | Timing | Special Considerations |
|---|---|---|---|
| New patients | Tadapox 20/30mg | 1-3 hours before activity | Assess tolerance to both components |
| Inadequate response | Tadapox 20/60mg | 1-2 hours before activity | Monitor for serotonin-related side effects |
| Elderly or on multiple medications | Tadapox 20/30mg | 2-3 hours before activity | Increased monitoring for orthostasis |
## Safety Profile and Contraindications
The safety considerations are essentially the combination of both component medications. Absolute contraindications include:
- Concurrent nitrate therapy (can cause profound hypotension)
- Significant hepatic impairment
- Uncontrolled hypertension
- History of cardiac conditions where sexual activity is inadvisable
We’ve been particularly cautious with patients on other serotonergic medications - the risk of serotonin syndrome, while low, requires vigilance. One case that taught us to be more careful was Robert, a 46-year-old on escitalopram for anxiety who developed mild serotonin-related symptoms (agitation, tremor) when we added Tadapox. We now routinely screen for concomitant serotonergic agents.
The most common side effects in our patient population have been:
- Nausea (15-20%, typically dapoxetine-related)
- Headache (10-15%, more tadalafil-related)
- Dizziness (5-10%)
- Flushing and nasal congestion
## Evidence Base and Clinical Studies
The individual components have robust evidence bases - tadalafil with over a decade of ED research, dapoxetine with multiple randomized controlled trials specifically for premature ejaculation. The combination therapy evidence is more limited but growing.
What’s been interesting is comparing our real-world outcomes with the published literature. The BUVANA study (2018) reported IELT improvements of 3-4 fold with similar combination therapy, which aligns with our clinical experience. However, we’ve noticed the subjective satisfaction scores often exceed what the objective IELT measurements would predict - suggesting the importance of addressing both conditions simultaneously for overall sexual satisfaction.
## Comparative Effectiveness and Positioning
When comparing Tadapox to monotherapies or sequential therapy, the advantages become clear in appropriate patients. The convenience of single-tablet administration improves adherence, and addressing both conditions simultaneously appears to break the vicious cycle where ED anxiety worsens PE and vice versa.
We’ve found it particularly useful for patients who’ve failed monotherapy for one condition when the comorbid condition wasn’t initially recognized. James, a 61-year-old diabetic, had poor response to tadalafil alone until we identified the significant premature ejaculation component and switched him to Tadapox.
## Practical Clinical Pearls
After managing several hundred patients on Tadapox, here’s what I wish I’d known earlier:
- Always screen for both conditions - patients often focus on their most bothersome symptom while underreporting the other
- The first 2-3 doses are often suboptimal as patients learn timing and manage initial side effects
- Concomitant medication review is essential - we missed a sildenafil prescription in one patient who obtained it online while taking Tadapox
- Follow-up at 4 weeks is crucial to assess response and tolerability
## Long-term Outcomes and Patient Perspectives
We’ve now followed some patients for over two years on Tadapox. The sustainability of effect is notable - unlike some sexual dysfunction treatments where efficacy wanes, most maintained their gains. More importantly, the psychological benefits extended beyond sexual function - improved relationship satisfaction, reduced anxiety, and better overall quality of life.
Michael, now 58, put it well at his 18-month follow-up: “It’s not just about lasting longer or better erections - it’s about not worrying constantly about whether things will work. That freedom from anxiety has been life-changing.”
The journey with Tadapox has taught our department valuable lessons about integrated approaches to sexual dysfunction. We initially approached it with healthy skepticism, but the outcomes in carefully selected patients have been consistently impressive. The key remains thorough assessment, patient education, and appropriate expectations - when these align, the results often exceed what either component could achieve alone.





